new milestones and changing standards of care in early egfr-mutated nsclc
Published 3 years ago • 181 plays • Length 1:02:40Download video MP4
Download video MP3
Similar videos
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
1:05:12
new horizons in egfr-mutated nsclc: broadening the impact of precision testing
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
28:28
patient selection, therapeutic sequencing, & treatment selection in egfr mutation-positive nsclc
-
6:08
flaura study: a new standard of care for patients with egfr mutated nsclc
-
6:50
osimertinib: a potential new standard of care for advanced egfr-mutated nsclc | suresh ramalingam
-
32:15
a visual exploration of new targeted therapies for egfr exon 20 insertions in nsclc
-
1:18:11
management of egfr-mutant lung cancer with central nervous system metastases
-
52:36
making precision decisions in the treatment of nsclc with common and uncommon egfr mutations
-
0:48
new standard of care for lung cancer patients with egfr mutations
-
1:00:53
drs. sepesi & cascone discuss egfr-targeted therapy in early-stage nsclc: https://bit.ly/3ozllfo
-
5:14
new standard for treating stage 4 egfr nsclc
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
13:26
debate: drug of choice for exon 19 del egfr mutant nsclc - any egfr tki
-
3:52
is adjuvant chemotherapy in egfr mutated nsclc still required?